As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...
The second infection was also tied to a 50% or greater increase in several specific long-COVID conditions, including ...
A new study by researchers from City St George's, University of London and the Ineos Oxford Institute for antimicrobial ...
A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ...
Recent research provides more support for the existence of long-term COVID and delves into potential causes and effects of ...
Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...
Evidence shows pausing BTKi therapy for COVID-19 vaccination does not affect antibody responses to the vaccine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback